Literature DB >> 1479559

Biopharmaceutical evaluation of ibufenac, ibuprofen, and their hydroxyethoxy analogs in the rabbit eye.

C S Rao1, R D Schoenwald, C F Barfknecht, S L Laban.   

Abstract

Two new structural analogs, 2-(4-hydroxyethoxyphenyl)acetic acid [R3] and 2-(4-hydroxyethoxyphenyl)propionic acid [R4], along with their parent compounds, ibufenac and ibuprofen, were evaluated for their biopharmaceutical properties. The analogs represented substitution of the lipophilic isobutyl side chains of ibufenac and ibuprofen with hydrophilic hydroxyethoxy side chains. Anti-inflammatory activity was evaluated by administering drugs topically to inhibit inflammation induced by using either clove oil or arachidonic acid. The rank order of activity was ibufenac approximately equal to ibuprofen > R3 approximately equal to R4. The new compounds, R3 and R4, were highly water soluble (> 60-fold) and partitioned less (< 1/1500-fold) into the lipid phase when compared to ibufenac and ibuprofen. R3 and R4 each had apparent corneal permeability coefficients of 6 x 10(-6) cm/sec, whereas ibufenac and ibuprofen yielded values of about 22 x 10(-6) cm/sec. In an ocular pharmacokinetic study in the rabbit eye, constant concentrations of each compound were maintained on the cornea in a cylinder or well fixed to the cornea, resulting in a constant input rate. This method circumvented parallel loss routes at the absorption site including nasolacrimal drainage. From area calculations the dispositions of the compounds within the eye were described by mean residence times, steady state volumes of distributions, and clearance rates. R3 and R4 were more slowly absorbed, retained within eye tissues longer, and were cleared more slowly from the eye than ibufenac and ibuprofen. The aqueous humor concentration-time profiles were also computer-fitted to equations representing classical pharmacokinetic models. For ibufenac and ibuprofen, the entire cornea was assumed to be the net barrier for entry into the anterior chamber. Whereas, for R3 and R4, the corneal epithelium and endothelium were presumed to be the diffusional barriers into and out of the stroma, the latter treated as a compartment. Aqueous humor concentrations of each drug fit the models reasonable well and agreed with conclusions made from the use of area calculations. The drop volume method was used to measure the surface tension of each compound. Both ibufenac and ibuprofen were considerably more surface active than R3 or R4. The greater surface tension measured for ibufenac and ibuprofen correlated to the subjective observations of ocular discomfort for these drugs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1479559     DOI: 10.1007/bf01062463

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  19 in total

1.  The effect of benzalkonium chloride on the electropotential of the rabbit cornea.

Authors:  K Green; A M Tonjum
Journal:  Acta Ophthalmol (Copenh)       Date:  1975-06

Review 2.  Ocular drug delivery. Pharmacokinetic considerations.

Authors:  R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

3.  Corneal penetration behavior of beta-blocking agents I: Physiochemical factors.

Authors:  R D Schoenwald; H S Huang
Journal:  J Pharm Sci       Date:  1983-11       Impact factor: 3.534

4.  Esterification of acidic anti-inflammatory drugs suppresses their gastrotoxicity without adversely affecting their anti-inflammatory activity in rats.

Authors:  M W Whitehouse; K D Rainsford
Journal:  J Pharm Pharmacol       Date:  1980-11       Impact factor: 3.765

5.  Topical carbonic anhydrase inhibitors IV: Relationship between excised corneal permeability and pharmacokinetic factors.

Authors:  M G Eller; R D Schoenwald; J A Dixson; T Segarra; C F Barfknecht
Journal:  J Pharm Sci       Date:  1985-05       Impact factor: 3.534

6.  The thickness-hydration relationship of the cornea.

Authors:  B O Hedbys; S Mishima
Journal:  Exp Eye Res       Date:  1966-07       Impact factor: 3.467

7.  Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits.

Authors:  V H Lee; J R Robinson
Journal:  J Pharm Sci       Date:  1979-06       Impact factor: 3.534

8.  Ocular pharmacokinetic models of clonidine-3H hydrochloride.

Authors:  C H Chiang; R D Schoenwald
Journal:  J Pharmacokinet Biopharm       Date:  1986-04

9.  Aqueous chamber drug distribution volume measurement in rabbits.

Authors:  J M Conrad; J R Robinson
Journal:  J Pharm Sci       Date:  1977-02       Impact factor: 3.534

10.  Ocular and systemic bioavailability of ophthalmic flurbiprofen.

Authors:  D D Tang-Liu; S S Liu; R J Weinkam
Journal:  J Pharmacokinet Biopharm       Date:  1984-12
View more
  3 in total

1.  Prediction of the corneal permeability of drug-like compounds.

Authors:  Heidi Kidron; Kati-Sisko Vellonen; Eva M del Amo; Anita Tissari; Arto Urtti
Journal:  Pharm Res       Date:  2010-04-13       Impact factor: 4.200

Review 2.  Topical ocular delivery of NSAIDs.

Authors:  Munish Ahuja; Avinash S Dhake; Surendra K Sharma; Dipak K Majumdar
Journal:  AAPS J       Date:  2008-04-25       Impact factor: 4.009

3.  Aliphatic β-nitroalcohols for therapeutic corneoscleral cross-linking: corneal permeability considerations.

Authors:  Quan Wen; Stephen L Trokel; MiJung Kim; David C Paik
Journal:  Cornea       Date:  2013-02       Impact factor: 2.651

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.